The Lithuanian company Northway Biotech, based in Vilnius, claims to have created an anti-coronavirus drug in cooperation with Swiss partners, LNK News reported on Thursday.
“We gave it to the Swiss for clinical trials, so the answer to the question whether a drug against the coronavirus has been created in Lithuania, I can say yes. It has been developed to a level where it is now undergoing clinical trials,” Vladas Bumelis, board chairman at Northway Biotech, said.
The results on the drug's efficacy are expected by the end of the year, according to him. The company is also developing another drug against Covid-19.
“We will start from scratch again with an American company,” Bumelis said.
He noted that the drug created in the Lithuanian laboratory could be the first in the world.
“There is no treatment against the coronavirus right now. The ones we are developing will have to be introduced eventually, since not all people will be willing to get vaccinated. If you are not vaccinated and you get sick, you will have something to be treated with,” he said.
Newsletter
Every Friday morning.
